The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

PHASE3RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2029

Conditions
Lung CancerGastric CancerEsophageal Cancer
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 Drops

1,000 - 10,000 units daily based on serum levels for the duration of the study

DIETARY_SUPPLEMENT

Coriolus Versicolor

1.5g twice daily for the duration of the study

DIETARY_SUPPLEMENT

Trident SAP 66:33 Lemon

3g once daily for the duration of the study

DIETARY_SUPPLEMENT

Probiotic Pro12

12 billion colony forming units daily during the peri-operative period (approximately 1 month pre and post-surgery)

DIETARY_SUPPLEMENT

Provitalix Pure Whey Protein

1 scoop (22g) once daily during the peri-operative period (approximately 1 month pre and post-surgery) and during any adjuvant chemotherapy and radiation treatments

DIETARY_SUPPLEMENT

Theracurmin 2X

1.2g twice daily after the peri-operative period. including during adjuvant chemotherapy and radiation

DIETARY_SUPPLEMENT

Green Tea Extract

700 mg twice daily after the peri-operative period. Will not be given during adjuvant radiation or chemotherapy treatments.

OTHER

Nutrition Recommendations

Based on the Mediterranean diet and lower glycemic index foods

OTHER

Physical Activity Recommendations

150 minutes moderate intensity aerobic exercise per week plus the addition of a resistance exercise program on 2 of those days

BEHAVIORAL

Psychological Recommendations

Activities with the intention of actively improving the participant's mental and emotional health

Trial Locations (2)

K1H 8L6

RECRUITING

The Ottawa Hospital, Ottawa

M4C 3E7

RECRUITING

Michael Garron Hospital, Toronto

All Listed Sponsors
collaborator

The Canadian College of Naturopathic Medicine

OTHER

collaborator

Lotte & John Hecht Memorial Foundation

OTHER

collaborator

The Centre for Health Innovation

UNKNOWN

collaborator

University of Ottawa

OTHER

lead

Ottawa Hospital Research Institute

OTHER